Get started
Author

Constant Gillot

Observed names: Gillot, Constant, constant Gillot
ORCID: 0000-0002-4151-9760
Observed ORCID: 0000-0002-4151-9760
OpenAlex ID: A5013384117
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers
2021 · Jean-Louis Bayart, Jonathan Douxfils, et al. · Vaccines · 135
PDF
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2
2021 · Julien Favresse, Constant Gillot, et al. · Viruses · 86
PDF
Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection
2021 · Julien Favresse, Constant Gillot, et al. · Journal of Clinical Medicine · 82
PDF
NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
2021 · Constant Gillot, Julien Favresse, et al. · Frontiers in Pharmacology · 58
PDF
Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection
2021 · Julien Favresse, Christine Eucher, et al. · Microorganisms · 54
PDF
Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant
2022 · Jean-Louis Bayart, Jonathan Degosserie, et al. · Viruses · 47
PDF
NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study
2022 · Laure Morimont, Mélanie Dechamps, et al. · Biomolecules · 43
PDF
Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster
2022 · Julien Favresse, Constant Gillot, et al. · Journal of Medical Virology · 33
PDF
An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens
2020 · Constant Gillot, Jonathan Douxfils, et al. · Journal of Clinical Medicine · 33
PDF
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
2022 · Julien Favresse, Jean-Louis Bayart, et al. · Viruses · 27
PDF
Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals
2023 · Jean-Louis Bayart, Constant Gillot, et al. · Journal of Clinical Virology · 26
PDF
Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
2021 · Jonathan Douxfils, Constant Gillot, et al. · Journal of Infection · 26
PDF
Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster
2024 · Julien Favresse, Constant Gillot, et al. · International Journal of Infectious Diseases · 25
PDF
Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients
2020 · Julien Favresse, Marc Elsen, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 16
PDF
Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects
2021 · Constant Gillot, Julien Favresse, et al. · Viruses · 12
PDF
Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature
2021 · Jonathan Douxfils, Constant Gillot, et al. · Vaccines · 11
PDF
Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster
2024 · Julien Favresse, Constant Gillot, et al. · Journal of Medical Virology · 10
PDF
Identification of SARS-CoV-2 Neutralizing Antibody with Pseudotyped Virus-based Test on HEK-293T hACE2 Cells
2022 · constant Gillot, Julien Favresse, et al. · BIO-PROTOCOL · 10
PDF
Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update
2024 · Constant Gillot, Clara David, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 9
An Evaluation of a SARS-CoV-2 Pseudovirus Neutralization Test and A Comparison to a SARS-CoV-2 Surrogate Virus Neutralization Test in a COVID-19 Long-Term Follow-Up Cohort
2024 · Constant Gillot, Julien Favresse, et al. · Microbiology Research · 9
PDF
Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing
2023 · Constant Gillot, Jean-Louis Bayart, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 9
PDF
Techniques for measuring NETosis: A critical literature review and outlook for standardization
2026 · Constant Gillot, Hachem Bouarroudj, et al. · Thrombosis Research · 8
Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration
2023 · Germain Simon, Julien Favresse, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 7
PDF
Device‐Induced Thrombosis in Blood‐Contacting Medical Devices: Mechanisms and Emerging Prevention Strategies
2026 · Constant Gillot, Pauline Michaux, et al. · Advanced Healthcare Materials · 6
Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19—BNT162b2 mRNA Vaccination
2022 · Emilie Catry, Julien Favresse, et al. · Viruses · 6
PDF
Works count: 41
Citation count: 802
H-index: 14
I10-index: 18
Year
Topic
Type